This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (84)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Nelson B. Watts, MD; Robert G. Spanheimer, MD; Mario DiGirolamo, MD; Suzanne S. P. Gebhart, MD; Victoria C. Musey, MD; Y. Khalid Siddiq, MD; Lawrence S. Phillips, MD

Arch Intern Med. 1990;150(4):803-806.

Abstract
• Although diet therapy is considered the cornerstone of therapy for obese patients with non–insulin-dependent diabetes mellitus, losing weight is often difficult, and the plasma glucose concentration does not always improve after weight loss. We looked for predictors of improvement in plasma glucose levels after weight loss in 135 obese patients with non-insulin-dependent diabetes mellitus who had lost at least 9.1 kg of body weight. After weight loss there was a bimodal distribution of plasma glucose levels, allowing us to identify patients as "responders" or "nonresponders" according to whether a random plasma glucose level was above or below 10.0 mmol/L after a 9.1-kg weight loss. Fifty-five (41%) of 135 patients were responders (after a 9.1-kg weight loss, the mean ± SEM plasma glucose level was 7.0±0.2 mmol/L). Many responders had improved plasma glucose levels after only slight weight loss. Eighty (59%) of 135 patients were nonresponders (after a 9.1-kg weight loss, the mean±SEM plasma glucose level was 18.3±0.6 mmol/L). Although the responder and nonresponder groups were comparable in age, sex distribution, plasma glucose levels, and body weight at initial presentation, improvement in the plasma glucose level after weight loss could be predicted by a plasma glucose level of 10.0 mmol/L or lower after 2.3-kg (62% positive predictive value) and 4.5-kg (79% positive predictive value) weight loss. We conclude that, in contrast to conventional teaching, many patients with non–insulin-dependent diabetes mellitus will not have any improvement in plasma glucose levels after a 9.1-kg weight loss. However, a substantial minority (40%) of obese patients with non–insulin-dependent diabetes mellitus have much lower plasma glucose levels with a weight loss of 9.1 kg or less. Although the plasma glucose response to weight loss cannot be forecast by initial clinical parameters, the success or failure of diet therapy can be predicted from the plasma glucose level after a weight loss of only 2.3 to 4.5 kg. Mild or moderately obese patients with non–insulin-dependent diabetes mellitus who remain hyperglycemic after a weight loss of 2.3 to 9.1 kg are unlikely to improve with further weight loss and should be considered for treatment with insulin or oral hypoglycemic agents.

(Arch Intern Med. 1990;150:803-806)

Author Affiliations
From the Division of Endocrinology and Metabolism, Department of Medicine, Emory University School of Medicine, Atlanta, Ga. Dr Spanheimer is now with the Department of Medicine, University of Iowa, Iowa City.

Footnotes
Accepted for publication October 30,1989.

Presented in part at the 46th Annual Meeting of the American Diabetes Association, Anaheim, Calif, June 24,1986.

Reprint requests to The Emory Clinic, 1365 Clifton Rd NE, Atlanta, GA 30322 (Dr Watts).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Dilemma of Weight Loss in Diabetes
Franz
Diabetes Spectr. 2007;20:133-136.
FULL TEXT  

Weight Management Using Lifestyle Modification in the Prevention and Management of Type 2 Diabetes: Rationale and Strategies
The American Diabetes Association et al.
Clin. Diabetes 2005;23:130-136.
FULL TEXT  

Patient Adherence Improves Glycemic Control
Rhee et al.
The Diabetes Educator 2005;31:240-250.
ABSTRACT | FULL TEXT  

Weight management through lifestyle modification for the prevention and management of type 2 diabetes: rationale and strategies. A statement of the American Diabetes Association, the North American Association for the Study of Obesity, and the American Society for Clinical Nutrition
Klein et al.
Am. J. Clin. Nutr. 2004;80:257-263.
ABSTRACT | FULL TEXT  

Weight Management Through Lifestyle Modification for the Prevention and Management of Type 2 Diabetes: Rationale and Strategies: A statement of the American Diabetes Association, the North American Association for the Study of Obesity, and the American Society for Clinical Nutrition
Klein et al.
Diabetes Care 2004;27:2067-2073.
FULL TEXT  

Effects of Moderate Weight Loss and Orlistat on Insulin Resistance, Regional Adiposity, and Fatty Acids in Type 2 Diabetes
Kelley et al.
Diabetes Care 2004;27:33-40.
ABSTRACT | FULL TEXT  

So Many Nutrition Recommendations--Contradictory or Compatible?
Franz
Diabetes Spectr. 2003;16:56-63.
FULL TEXT  

Evolution of diabetes medical nutrition therapy
Franz et al.
Postgrad. Med. J. 2003;79:30-35.
ABSTRACT | FULL TEXT  

2002 Diabetes Nutrition Recommendations: Grading the Evidence
Franz
The Diabetes Educator 2002;28:756-766.
 

American Association of Clinical Endocrinologists Meeting, May 2002
Bloomgarden
Diabetes Care 2002;25:1464-1471.
FULL TEXT  

Clinical Efficacy of Orlistat Therapy in Overweight and Obese Patients With Insulin-Treated Type 2 Diabetes: A 1-year randomized controlled trial
Kelley et al.
Diabetes Care 2002;25:1033-1041.
ABSTRACT | FULL TEXT  

Evidence-Based Nutrition Principles and Recommendations for the Treatment and Prevention of Diabetes and Related Complications
Franz et al.
Diabetes Care 2002;25:148-198.
FULL TEXT  

Weight Loss, Diets, and Supplements: Does Anything Work?
Boucher et al.
Diabetes Spectr. 2001;14:169-175.
FULL TEXT  

Does "Diet" Fail?
Franz et al.
The Diabetes Educator 2001;27:563-570.
 

The Answer to Weight Loss Is Easy--Doing It Is Hard!
Franz
Clin. Diabetes 2001;19:105-109.
ABSTRACT | FULL TEXT  

Effects of Weight Loss With Orlistat on Glucose Tolerance and Progression to Type 2 Diabetes in Obese Adults
Heymsfield et al.
Arch Intern Med 2000;160:1321-1326.
ABSTRACT | FULL TEXT  

Is Obesity Related to Microvascular and Macrovascular Complications in Diabetes? The Wisconsin Epidemiologic Study of Diabetic Retinopathy
Klein et al.
Arch Intern Med 1997;157:650-656.
ABSTRACT  

Diabetes Health Beliefs, Self-Care Behaviors, and Glycemic Control Among Older Adults With Non-Insulin-Dependent Diabetes Mellitus
Polly
The Diabetes Educator 1992;18:321-327.
 

Early Pharmacotherapy in Non-Insulin-Dependent Diabetes Mellitus: Help or Hindrance?-Reply
Watts
Arch Intern Med 1991;151:201-201.
ABSTRACT  

Early Pharmacotherapy in Non-Insulin-Dependent Diabetes Mellitus: Help or Hindrance?
Sheehan and Ulchaker
Arch Intern Med 1991;151:198-201.
ABSTRACT  

THE GLYCEMIC RESPONSE TO WEIGHT LOSS IN OBESE DIABETIC PATIENTS
JWatch General 1990;1990:3-3.
FULL TEXT